Predictive Technology EPS - Earnings per Share 2017-2021 | PRED
Predictive Technology eps - earnings per share from 2017 to 2021. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Predictive Technology Annual EPS | |
|---|---|
| 2020 | $-0.30 |
| 2019 | $-0.06 |
| 2018 | $-0.03 |
| 2017 | $-0.03 |
| 2016 | $-0.10 |
| Predictive Technology Quarterly EPS | |
|---|---|
| 2021-03-31 | $-0.02 |
| 2020-12-31 | $-0.02 |
| 2020-09-30 | $-0.05 |
| 2020-06-30 | $-0.13 |
| 2020-03-31 | $-0.05 |
| 2019-12-31 | $-0.09 |
| 2019-09-30 | $-0.03 |
| 2019-06-30 | $-0.03 |
| 2019-03-31 | $-0.01 |
| 2018-12-31 | $-0.01 |
| 2018-09-30 | $-0.01 |
| 2018-06-30 | $-0.02 |
| 2018-03-31 | $-0.01 |
| 2017-12-31 | $-0.00 |
| 2017-09-30 | $-0.00 |
| 2017-06-30 | $0.00 |
| 2016-06-30 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.000B | $0.000B |
| Predictive Technology Group, Inc. is a therapeutics and life sciences company, in the use of data analytics for disease identification and subsequent therapeutic intervention through unique novel gene-based diagnostics, biotechnology treatments and companion therapeutics. The company through its' wholly-owned subsidiaries Predictive Therapeutics and Predictive Biotech focuses on clinical categories consists of Endometriosis, Scoliosis, Degenerative Disc Disease and Regenerative Human Cell and Tissue Products. Predictive Biotech efforts to advance regenerative medicine and Predictive Therapeutics is committed to assisting women in overcoming the devastating consequences of endometriosis via appropriate early-stage diagnosis and subsequent treatment. Predictive Technology Group, Inc. is based in Salt Lake City, UT. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.170B | 20.41 |
| Inspire Medical Systems (INSP) | United States | $7.442B | 0.00 |
| Axonics (AXNX) | United States | $3.438B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.304B | 0.00 |
| 10x Genomics (TXG) | United States | $3.115B | 0.00 |
| Azenta (AZTA) | United States | $3.074B | 250.59 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.887B | 0.00 |
| Enovis (ENOV) | United States | $2.865B | 21.24 |
| Hims & Hers Health (HIMS) | United States | $2.646B | 0.00 |
| Privia Health (PRVA) | United States | $2.284B | 101.32 |
| Schrodinger (SDGR) | United States | $1.715B | 0.00 |
| Omnicell (OMCL) | United States | $1.391B | 48.10 |
| Phreesia (PHR) | United States | $1.274B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.854B | 0.00 |
| Standard BioTools (LAB) | United States | $0.688B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.638B | 0.00 |
| Talkspace (TALK) | United States | $0.456B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.400B | 0.00 |
| Pulmonx (LUNG) | United States | $0.370B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.367B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.324B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.225B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.210B | 0.00 |
| Outset Medical (OM) | United States | $0.196B | 0.00 |
| American Well (AMWL) | United States | $0.161B | 0.00 |
| Augmedix (AUGX) | United States | $0.133B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.123B | 0.00 |
| TruBridge (TBRG) | United States | $0.119B | 5.09 |
| 111 (YI) | China | $0.098B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.088B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.067B | 0.00 |
| Zepp Health (ZEPP) | China | $0.054B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Movano (MOVE) | United States | $0.044B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.043B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| ETAO (ETAO) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |